Idera Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Idera Pharmaceuticals patents 8 in total

Status Patent
Application
Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: TLR9 MODULATORS FOR TREATING CANCER External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19 External link
Filling date: 8 Sep 2025 Issue date: 14 Oct 2021
Application
Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 7 May 2020
Application
Utility: TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS External link
Filling date: 8 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT External link
Filling date: 8 Sep 2025 Issue date: 20 Feb 2020

Showing 1 to 8 of 8 patents.